SCHEMBL256443

SCHEMBL256443

Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3cc(OCCN4CCCCC4)ccc23)n[nH]1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.60
CYP3A4 P08684 3/20 0.60
CYP2C8 P10632 3/20 0.60
CYP2C9 P11712 3/20 0.60
JAK1 P23458 3/20 0.60
TYK2 P29597 3/20 0.60
CYP2C19 P33261 3/20 0.60
JAK3 P52333 3/20 0.60
ADORA3 P0DMS8 2/20 0.60
CYP1A2 P05177 1/20 0.60
AURKA O14965 8/20 0.48
AURKB Q96GD4 4/20 0.42
SYK P43405 2/20 0.41
LTA4H P09960 2/20 0.40
GRK6 P43250 1/20 0.40
NTRK1 P04629 2/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10224893 0.92 JAK2 (0.58) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL173552 0.92 JAK2 (0.58) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL174030 0.92 JAK2 (0.58) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL174031 0.92 JAK2 (0.58) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL13186839 0.87 JAK2 (0.68) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL188252 0.87 JAK2 (0.68) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL164807 0.87 JAK2 (0.68) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL187661 0.86 JAK2 (0.67) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL10224897 0.86 JAK2 (0.67) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL255867 0.86 JAK2 (0.67) JAK2CYP3A4CYP2C8CYP2C9JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030918-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed